BCM
Boxer Capital Management Portfolio holdings
AUM
$199M
This Quarter Return
+9.43%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.17B
AUM Growth
–
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
60.16%
Holding
60
New
60
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Revolution Medicines
RVMD
|
$187M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$124M |
| 3 |
Nuvalent
NUVL
|
$87.7M |
| 4 |
Merus
MRUS
|
$79.9M |
| 5 |
Avidity Biosciences
RNA
|
$50.2M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zentalis Pharmaceuticals
ZNTL
$126M
| $1.36M | 0.12% |
+450,000
| New | +$1.36M |
|
52
Black Diamond Therapeutics
BDTX
$167M
| $1.08M | 0.09% |
+506,000
| New | +$1.08M |
|
53
Orchestra BioMed
OBIO
$148M
| $953K | 0.08% |
+238,193
| New | +$953K |
|
54
Zura Bio
ZURA
$143M
| $750K | 0.06% |
+300,000
| New | +$750K |
|
55
Milestone Pharmaceuticals
MIST
$153M
| $729K | 0.06% |
+309,007
| New | +$729K |
|
|
BOLD
56
Boundless Bio
BOLD
$25.7M
| $725K | 0.06% |
+250,000
| New | +$725K |
|
57
BioAtla
BCAB
$31.5M
| $406K | 0.03% |
+686,347
| New | +$406K |
|
|
DBVT
58
DBV Technologies
DBVT
$245M
| $155K | 0.01% |
+50,000
| New | +$155K |
|
59
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$64.6M
| $61.3K | 0.01% |
+266,666
| New | +$61.3K |
|
60
Surrozen, Inc. Warrant
SRZNW
$71K
| $1.66K | ﹤0.01% |
+66,666
| New | +$1.66K |
|